Elevated circulating branched chain amino acids are an early event in pancreatic adenocarcinoma development

Most patients with pancreatic ductal adenocarcinoma (PDAC) are diagnosed with advanced disease and survive less than 12 months(1). PDAC has been linked with obesity and glucose intolerance(2-4), but whether changes in circulating metabolites are associated with early cancer progression is unknown. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayers, Jared R., Wu, Chen, Clish, Clary B., Kraft, Peter, Torrence, Margaret E., Fiske, Brian P., Yuan, Chen, Bao, Ying, Townsend, Mary K., Tworoger, Shelley S., Davidson, Shawn M., Papagiannakopoulos, Thales, Yang, Annan, Dayton, Talya L., Ogino, Shuji, Stampfer, Meir J., Giovannucci, Edward L., Qian, Zhi Rong, Rubinson, Douglas A., Ma, Jing, Sesso, Howard D., Gaziano, John Michael, Cochrane, Barbara B., Liu, Simin, Wactawski–Wende, Jean, Manson, JoAnn E., Pollak, Michael N., Kimmelman, Alec C., Souza, Amanda, Pierce, Kerry, Wang, Thomas J., Gerszten, Robert E., Fuchs, Charles S., Heiden, Matthew G. Vander, Wolpin, Brian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191991/
https://www.ncbi.nlm.nih.gov/pubmed/25261994
http://dx.doi.org/10.1038/nm.3686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191991/
https://www.ncbi.nlm.nih.gov/pubmed/25261994
http://dx.doi.org/10.1038/nm.3686

Ejemplares similares